August 8, 2026
The Twenty-Year Vigil: Shira Kolat’s Journey Through Genetic Risk and Triple-Negative Breast Cancer the-twenty-year-vigil-shira-kolats-journey-through-genetic-risk-and-triple-negative-breast-cancer

The Twenty-Year Vigil: Shira Kolat’s Journey Through Genetic Risk and Triple-Negative Breast Cancer

Raul Delapena Setiawan August 1, 2026
GAITHERSBURG, MD — For many cancer patients, the diagnosis arrives as a sudden, earth-shattering bolt from the...
Read More Read more about The Twenty-Year Vigil: Shira Kolat’s Journey Through Genetic Risk and Triple-Negative Breast Cancer
Beyond the Waistline: The Metamorphosis of GLP-1 Research and the Race for Specialized Biospecimens beyond-the-waistline-the-metamorphosis-of-glp-1-research-and-the-race-for-specialized-biospecimens

Beyond the Waistline: The Metamorphosis of GLP-1 Research and the Race for Specialized Biospecimens

Azzam Bilal Chamdy July 31, 2026
The pharmaceutical landscape has been fundamentally altered by the meteoric rise of glucagon-like peptide-1 (GLP-1) receptor agonists....
Read More Read more about Beyond the Waistline: The Metamorphosis of GLP-1 Research and the Race for Specialized Biospecimens
Selinexor Trial for Advanced Endometrial Cancer Falls Short of Primary Endpoint, Sparking Stock Plunge and Strategic Re-evaluation selinexor-trial-for-advanced-endometrial-cancer-falls-short-of-primary-endpoint-sparking-stock-plunge-and-strategic-re-evaluation

Selinexor Trial for Advanced Endometrial Cancer Falls Short of Primary Endpoint, Sparking Stock Plunge and Strategic Re-evaluation

Basiran July 31, 2026
Boston, MA – [Insert Date] – Karyopharm Therapeutics Inc. has announced a significant setback in its clinical...
Read More Read more about Selinexor Trial for Advanced Endometrial Cancer Falls Short of Primary Endpoint, Sparking Stock Plunge and Strategic Re-evaluation
A Decade of Hope: Landmark Penn Medicine Study Suggests Potential Cures for B-Cell Lymphoma Through CAR T-Cell Therapy a-decade-of-hope-landmark-penn-medicine-study-suggests-potential-cures-for-b-cell-lymphoma-through-car-t-cell-therapy

A Decade of Hope: Landmark Penn Medicine Study Suggests Potential Cures for B-Cell Lymphoma Through CAR T-Cell Therapy

Asro July 31, 2026
In a medical landscape often defined by incremental progress, a decade-long study from the Abramson Cancer Center...
Read More Read more about A Decade of Hope: Landmark Penn Medicine Study Suggests Potential Cures for B-Cell Lymphoma Through CAR T-Cell Therapy

You may have missed

the-dismantling-of-u-s-global-health-assessing-the-impact-of-the-new-executive-mandates

The Dismantling of U.S. Global Health: Assessing the Impact of the New Executive Mandates

Azzam Bilal Chamdy August 8, 2026
the-cosmic-pivot-navigating-the-solar-eclipse-and-the-shift-of-mercury-and-mars-august-9-15-2026

The Cosmic Pivot: Navigating the Solar Eclipse and the Shift of Mercury and Mars (August 9–15, 2026)

Neng Nana August 8, 2026
a-new-frontier-in-cancer-immunotherapy-kings-college-london-unveils-groundbreaking-ige-antibody-treatment

A New Frontier in Cancer Immunotherapy: King’s College London Unveils Groundbreaking IgE Antibody Treatment

Reynand Wu August 8, 2026
zimmer-biomet-surges-q2-financials-spark-market-confidence-and-upgraded-2026-outlook

Zimmer Biomet Surges: Q2 Financials Spark Market Confidence and Upgraded 2026 Outlook

Reynand Wu August 8, 2026